{"id":"ads-8902","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"The exact mechanism by which ADAMS-8902 exerts its effects is not yet fully understood, as it is still in the early stages of clinical development.","oneSentence":"ADAMS-8902's mechanism of action is currently under investigation and not fully characterized.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:20:00.736Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT00979251","phase":"PHASE2","title":"Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects","status":"COMPLETED","sponsor":"Adamas Pharmaceuticals, Inc.","startDate":"2009-09","conditions":"Influenza","enrollment":2}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Amantadine Hydrochloride","Rebetol®","Tamiflu®"],"phase":"phase_2","status":"active","brandName":"ADS-8902","genericName":"ADS-8902","companyName":"Adamas Pharmaceuticals, Inc.","companyId":"adamas-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}